Royalty Management Holding Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Royalty Management Holding Corporation on October 31, 2024. The report addresses a regulatory notice received from the Nasdaq Stock Market regarding the Company's compliance with listing standards.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a listing compliance issue rather than financial performance data.
Material Changes and Events
- Delisting Notice: On October 28, 2024, the Company received notice from Nasdaq that its stock failed to maintain a minimum closing bid price of $1.00 per share for 31 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2).
- Immediate Impact: The notification has no immediate effect on the listing or trading of the Company's stock on the Nasdaq Capital Market.
Outlook, Risks, and Contingencies
- Compliance Period: The Company has 180 calendar days from the notification date (until April 28, 2025) to regain compliance.
- Compliance Criteria: To regain compliance, the closing bid price must be at or above $1.00 for a minimum of 10 consecutive business days within the compliance period.
- Secondary Compliance Option: If the bid price requirement is not met by April 28, 2025, the Company may be eligible for an additional 180-day period to meet other initial listing standards (excluding the bid price requirement) by providing written notice of its intention to cure the deficiency.
- Delisting Risk: If the Company fails to cure the deficiency or is ineligible for the second compliance period, Nasdaq will issue a notice that the common stock will be subject to delisting.
Investor Verification Checklist
- Verify the current closing bid price of the stock to assess proximity to the $1.00 threshold.
- Monitor the Company's stock price daily to determine if the 10 consecutive business days requirement can be met before April 28, 2025.
- Review future filings for any written notice of intention to cure the deficiency if the initial compliance period expires without success.
- Check for any subsequent announcements regarding the Company's market value of publicly held shares if a second compliance period is initiated.